GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Celecoxib (Celebrex), oral capsule

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Celebrex - labeled renal guidance

Product / population
Celecoxib (Celebrex), oral capsule
Renal method
Renal impairment categories as defined by the cited product label
Source revision
DailyMed SPL version 13, posted Dec 18, 2025
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Celebrex - product and source limitations

Monitor renal function and volume status if clinical circumstances justify use.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Celebrex - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Celecoxib (Celebrex), oral capsule

Renal method: Renal impairment categories as defined by the cited product label
Source date: DailyMed SPL version 13, posted Dec 18, 2025
Retrieved: 2026-11-07

Restriction or avoidance guidance. Read the specific threshold, age, formulation and dialysis exclusions; do not generalize across products.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: Oligohydramnios/Neonatal Renal Impairment / 8.7 Renal Impairment / Renal Impairment

Severe renal insufficiency is a reason to avoid routine celecoxib treatment. Monitor renal function and volume status if clinical circumstances justify use.

RDM74-celebrex-official-1 · Source locator: Renal guidance: Oligohydramnios/Neonatal Renal Impairment / 8.7 Renal Impairment / Renal Impairment

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d6675e4-5859-4be2-8037-a20ce9f707aa
Retrieved
2026-11-07
Renal-function method
Renal impairment categories as defined by the cited product label
Source date/version
DailyMed SPL version 13, posted Dec 18, 2025
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
85bd322557dba35e973a551398d22b65080874c0485c04dbde8feca3cc2f4584

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=rx-celebrex&s1=RDM74-celebrex-official&h1=1f3081c8b1c5d95cfeff9de8c964fb0edff660ede5f409d6de67a16f3fb0b29e

Top